DE4CC0DE-5FC3-4494-BCBF-4D50B00366B5
Drinks

Beam Suntory To Sell Maxxium Russia Joint Venture

By Dayeeta Das
Share this article
Beam Suntory To Sell Maxxium Russia Joint Venture

Spirits giant Beam Suntory and its partner Edrington have agreed to sell the Maxxium Russia joint venture business to the local management team.

After suspending shipments to Russia following the invasion of Ukraine in early March, Beam Suntory began reviewing approaches to the future of its Russian business.

The spirits giant believes that the best way to exit the market was through a sale of the Russia joint venture to the local management team.

Shipments from Beam Suntory will remain suspended, the company added, as it continues to abide by all applicable laws, including international sanctions.

In January 2021, Beam Suntory announced plans to move its global headquarters to New York City in mid-2022.

ADVERTISEMENT

The Jim Beam parent planned to relocate most of its executive leadership team positions, global brand house organisation, and select global corporate function roles to Manhattan.

Exit From Russia

Elsewhere, Diageo, the world's largest spirits maker, announced plans to wind down its business operations in Russia over the next six months. However, it will retain a business licence there that requires a number of employees to remain, according to Reuters. The spirits giant stopped shipping to and selling goods in Russia in March.

In April, Anheuser-Busch InBev announced plans to sell its stake in Russian joint-venture AB InBev Efes, which it said would result in a $1.1 billion (€1.02 billion) impairment charge in its first quarter results.

© 2022 European Supermarket Magazine – your source for the latest drinks news. Article by Dayeeta Das. Click subscribe to sign up to ESM: European Supermarket Magazine.

Get the week's top grocery retail news

The most important stories from European grocery retail direct to your inbox every Thursday

Processing your request...

Thanks! please check your email to confirm your subscription.

By signing up you are agreeing to our terms & conditions and privacy policy. You can unsubscribe at any time.